Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Providing Medicaid Average Wholesale Drug Prices To Medicare Carriers

Executive Summary

Prescription drug pricing data developed for Medicaid will be transmitted to Medicare carriers in June for use in determining Medicare drug allowances, HHS Secretary Donna Shalala said in a May 31 letter to House Commerce Committee Chairman Bliley (R-Va.)

You may also be interested in...



HCFA Reform, Drug Pricing Protections Urged Prior To Medicare Expansion

Health Care Financing Administration reform must precede the adoption of a Medicare prescription drug benefit, Commerce Committee Chairman Bliley (R-Va.) declared in a Sept. 25 letter to HCFA Administrator Nancy-Ann DeParle.

HCFA Reform, Drug Pricing Protections Urged Prior To Medicare Expansion

Health Care Financing Administration reform must precede the adoption of a Medicare prescription drug benefit, Commerce Committee Chairman Bliley (R-Va.) declared in a Sept. 25 letter to HCFA Administrator Nancy-Ann DeParle.

House Medicare Rx Bill Calls For GAO Study Of Part B Payments Prior To Cuts

The General Accounting Office would conduct a study of Medicare payment levels for currently covered drugs and biologics under an amendment to Medicare prescription drug legislation that was approved by the House Ways & Means Committee June 21.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel